Retinal Vein Occlusion: all 291 studies

Page 1 of 3. Open to participants first (29), then studies with results posted, then the rest; newest registration first within each.

• Iopidine to Decrease Intraocular Pressure Rise After InjectionsNot yet recruitingNCT07891910Phase 4
• Changes in Intraocular Pressure After Intravitreal InjectionNot yet recruitingNCT07826286
• Robotic RVO Trial: Robot-assisted Retinal Vein Cannulation in Patients With Retinal Vein OcclusionsRecruitingNCT07820761Not applicable
• A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein OcclusionNot yet recruitingNCT07817615Phase 1
• A Study on the Combination of Tongluo Huayu Formula in Treating RVO of Phlegm-Stasis Intertwinement Type: Based on the Mechanism of Systemic Metabolic Regulation Mediated by Gut MicrobiotaNot yet recruitingNCT07718503Not applicable
• Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal BevacizumabRecruitingNCT07550777
• Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsEnrolling by invitationNCT07456826Phase 4
• AI vs. Physician for Anti-VEGF Decision-Making: An RCTNot yet recruitingNCT07328776Not applicable
• DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.RecruitingNCT07308639
• Wide Field OCTA in Ocular DiseasesNot yet recruitingNCT07298174
• Retinal Clinical Assessment With AI-derived Quantitative InformationNot yet recruitingNCT07291960
• Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein OcclusionRecruitingNCT07259928Phase 2
• High-throughput Large-model-based AI-assisted Diagnosis Using OCTNot yet recruitingNCT07249307
• Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
• A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVORecruitingNCT07205887Phase 2
• Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion TreatmentRecruitingNCT07133438Phase 4
• Effect of Video Viewing on Intravitreal Injection ExperienceRecruitingNCT07002372Not applicable
• Optical Coherence Tomography in Retinal Vein OcclusionNot yet recruitingNCT06886893
• Evaluation of Therapeutic Efficacy of Faricimab for Clinical AMD, DME, and RVO PatientsRecruitingNCT06572553Phase 2/3
• Intraoperative Application of Fluorescein Sodium Angiography in Vascular RetinopathyNot yet recruitingNCT06343961Not applicable
• OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVORecruitingNCT06332690
• Single-center Study Measuring OSDI Dry Eye Score in Patients Undergoing an Anti-VEGF Induction ProtocolRecruitingNCT06262737
• NIR Fluorescence Molecular Imaging of ANXV-800CW in RVO PatientsRecruitingNCT05133791Phase 1
• Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruitingNCT04505618Not applicable
• Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein OcclusionRecruitingNCT04140448
• Ultra-wide-field Fluorescein Angiography in Patients With Retinal Vein OcclusionRecruitingNCT04075695
• Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumRecruitingNCT04008121Early Phase 1
• Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic RetinopathiesRecruitingNCT03680794Not applicable
• National Eye Institute Biorepository for Retinal DiseasesRecruitingNCT01496625
• A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVOCompletedNCT06176963Phase 2Results posted
• Cool vs Room-temperature Artificial TearsCompletedNCT05832996Phase 4Results posted
• Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein OcclusionCompletedNCT04812977Not applicableResults posted
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Central Retinal or Hemiretinal Vein OcclusionCompletedNCT04740931Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein OcclusionCompletedNCT04740905Phase 3Results posted
• Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF TreatmentTerminatedNCT04707625Phase 4Results posted
• A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT04592419Phase 3Results posted
• A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal DisordersCompletedNCT04516278Phase 3Results posted
• A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein OcclusionCompletedNCT04085341Phase 2Results posted
• Treatment of Central Retinal Vein Occlusion Using Stem Cells StudyCompletedNCT03981549Phase 1/2Results posted
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionTerminatedNCT03810313Phase 3Results posted
• Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein OcclusionTerminatedNCT03802630Phase 3Results posted
• Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT03739593Phase 2Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Anti-VEGF in Subjects With Macular Edema Following RVOTerminatedNCT03203447Phase 3Results posted
• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)CompletedNCT03093701Phase 2Results posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOTerminatedNCT02980874Phase 3Results posted
• Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and SafetyCompletedNCT02953938Phase 4Results posted
• Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVOCompletedNCT02800642Phase 4Results posted
• A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)CompletedNCT02698566Phase 3Results posted
• Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME.CompletedNCT02571972Phase 2Results posted
• SD-OCT AngiographyTerminatedNCT02510885Not applicableResults posted
• Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVOCompletedNCT02503540Phase 4Results posted
• Philadelphia Telemedicine Glaucoma Detection and Follow-Up StudyCompletedNCT02390245Not applicableResults posted
• Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVOCompletedNCT02303184Phase 2Results posted
• Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular EdemaCompletedNCT02245516Not applicableResults posted
• Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX®CompletedNCT02181530Results posted
• Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema.CompletedNCT02140411Phase 4Results posted
• Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGFCompletedNCT02118831Phase 1/2Results posted
• Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVOCompletedNCT02006147Phase 1/2Results posted
• Safety and Efficacy of Dexamethasone (OZURDEX®) Intravitreal Implant in KoreaCompletedNCT01976650Results posted
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01976338Phase 3Results posted
• Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01976312Phase 3Results posted
• Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)CompletedNCT01969708Phase 3Results posted
• A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular EdemaCompletedNCT01918371Results posted
• A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein OcclusionCompletedNCT01903720Phase 4Results posted
• Ozurdex for Retinal Vein Occlusion Study (ORVO Study)CompletedNCT01790685Phase 2/3Results posted
• Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein OcclusionCompletedNCT01710839Phase 4Results posted
• Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLOCompletedNCT01692938Results posted
• Anesthesia Preference for Intravitreal Injection: Topical or SubconjunctivalCompletedNCT01640171Not applicableResults posted
• Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein OcclusionCompletedNCT01618266Results posted
• Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein OcclusionCompletedNCT01614509Not applicableResults posted
• Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein OcclusionCompletedNCT01599650Phase 3Results posted
• Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVOCompletedNCT01580020Phase 4Results posted
• Extension Study to Gather Data on Effect of Macugen on the Corneal EndotheliumCompletedNCT01573572Phase 4Results posted
• A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO)CompletedNCT01571557Results posted
• Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO)CompletedNCT01568021Results posted
• Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein OcclusionCompletedNCT01566526Results posted
• Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein OcclusionCompletedNCT01535261Phase 3Results posted
• Study to Assess the Clinical Efficacy and Safety of Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321) in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01521559Phase 3Results posted
• Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving BevacizumabCompletedNCT01471691Phase 1/2Results posted
• Minocycline to Treat Central Retinal Vein OcclusionCompletedNCT01468844Phase 1/2Results posted
• Minocycline to Treat Branch Retinal Vein OcclusionCompletedNCT01468831Phase 1/2Results posted
• Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections.CompletedNCT01449682Phase 3Results posted
• An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)CompletedNCT01442064Not applicableResults posted
• Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein OcclusionCompletedNCT01427751Phase 4Results posted
• Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO)CompletedNCT01411696Results posted
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)CompletedNCT01396083Phase 3Results posted
• Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)CompletedNCT01396057Phase 3Results posted
• A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein OcclusionCompletedNCT01277302Phase 4Results posted
• REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab StudyCompletedNCT01247220Phase 2Results posted
• Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)CompletedNCT01231633Not applicableResults posted
• Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)TerminatedNCT01225146Phase 1Results posted
• Extended Follow-up of Patients With Macular Edema Due to Retinal Vein OcclusionCompletedNCT01198327Phase 3Results posted
• Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein OcclusionCompletedNCT01085734Phase 4Results posted
• Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)CompletedNCT01027650Phase 1/2Results posted
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT01012973Phase 3Results posted
• Ranibizumab DosE Comparison and the Role of LAser in REtinal Vein OcclusionsCompletedNCT01003106Phase 1/2Results posted
• A Study of a Sustained Release Fluocinolone Implant for Treatment of Central Retinal Vein OcclusionCompletedNCT00952614Not applicableResults posted
• Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)CompletedNCT00943072Phase 3Results posted
• Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in RetinaTerminatedNCT00770770Phase 2Results posted
• Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein OcclusionsTerminatedNCT00500045Phase 2/3Results posted

← Retinal Vein Occlusion overview